Gentamycin C213

The Gentamycin C213 test, offered at IntroLab in Belgrade, enables accurate monitoring of gentamicin levels in the body, ensuring proper therapy and faster recovery.

What is Gentamycin?

Gentamycin is an antibiotic from the aminoglycoside group, effective against a wide range of bacterial infections, especially gram-negative bacteria. It is commonly used in hospital settings to treat serious infections caused by complex bacterial strains. Gentamycin works by inhibiting protein synthesis in bacteria, preventing their growth and reproduction. However, its use carries certain risks, including:

• Ototoxicity (hearing damage)
• Nephrotoxicity (kidney damage)

When and why is the Gentamycin C213 test performed?

The Gentamycin C213 test is primarily used to monitor the concentration of gentamicin in a patient’s body, which is essential for ensuring proper dosing of this antibiotic. It is often recommended before starting gentamicin therapy to establish a baseline concentration, and then periodically during treatment to ensure optimal effectiveness and prevent harmful side effects such as ototoxicity and nephrotoxicity. By monitoring gentamicin levels, doctors can accurately adjust the antibiotic dosage based on the patient’s individual needs, reducing the risk of toxicity and increasing the chances of successfully treating bacterial infections.